PA
CMD

Procyon Advisors’s Cantel Medical Corporation CMD Stock Holding History

Procyon Advisors’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-111
Closed -$4K – 1227
2020
Q1 		$4K Sell
111
-20
-15% -$1.14K ﹤0.01% 785
2019
Q4 		$9K Buy
+131
New +$9.5K 0.01% 693

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Procyon Advisors's CMD Position: Q2 2020 in Review

Procyon Advisors sold out of Cantel Medical Corporation (CMD) in Q2 2020, closing a stake of 111 shares — an estimated $4K sold.

Procyon Advisors first reported a position in CMD in Q4 2019 and held it in 2 quarters. The position peaked at $9K in Q4 2019. 210 funds tracked by Wall St. Rank hold CMD as of Q2 2020.

  • Procyon Advisors reported no remaining Cantel Medical Corporation position as of Q2 2020 after selling out during the quarter.
  • Procyon Advisors sold 111 Cantel Medical Corporation shares in Q2 2020, an estimated $4K.
  • Procyon Advisors first reported a position in Cantel Medical Corporation in Q4 2019 and held it in 2 quarters.
  • Procyon Advisors's Cantel Medical Corporation position peaked at $9K in Q4 2019.
  • 210 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2020.

Based on Procyon Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.